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Summary
Remodeling of the actin cytoskeleton is required for
vasopressin (VP)-induced aquaporin 2 (AQP2) trafficking.
Here, we asked whether VP and forskolin (FK)-mediated F-
actin depolymerization depends on AQP2 expression. Using
various MDCK and LLC-PK1 cell lines with different AQP2
expression levels, we performed F-actin quantification and
immunofluorescence staining after VP/FK treatment. In
MDCK cells, in which AQP2 is delivered apically, VP/FK
mediated F-actin depolymerization was significantly
correlated with AQP2 expression levels. A decrease of
apical membrane associated F-actin was observed upon VP/
FK treatment in AQP2 transfected, but not in untransfected
cells. There was no change in basolateral actin staining under
these conditions. In LLC-PK1 cells, which deliver AQP2
basolaterally, a significant VP/FK mediated decrease in
F-actin was also detected only in AQP2 transfected
cells. This depolymerization response to VP/FK was
significantly reduced by siRNA knockdown of AQP2. By
immunofluorescence, an inverse relationship between plasma
membrane AQP2 and membrane-associated F-actin was
observed after VP/FK treatment again only in AQP2
transfected cells. This is the first report showing that VP/
FK mediated F-actin depolymerization is dependent on AQP2
protein expression in renal epithelial cells, and that this is not
dependent on the polarity of AQP2 membrane insertion.
 2011. Published by The Company of Biologists Ltd. This is
an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial Share Alike
License (http://creativecommons.org/licenses/by-nc-sa/3.0).
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Introduction
AQP2 is expressed in renal collecting duct principal cells and is
critical for water reabsorption and urine concentration (Brown,
2003; Deen and Knoers, 1998; Fushimi et al., 1997; Fushimi et
al., 1993; Katsura et al., 1997; Knepper et al., 1997; Nielsen et
al., 2002). Vasopressin (VP) binding to the vasopressin type 2
receptor (V2R) triggers AQP2 plasma membrane accumulation
via intracellular cAMP elevation, PKA activation (Katsura et al.,
1997; Klussmann et al., 1999; Kuwahara et al., 1995) and AQP2
phosphorylation pattern changes (Fenton et al., 2008; Fushimi et
al., 1997; Hoffert et al., 2008; Hoffert et al., 2007; Katsura et al.,
1997; Moeller et al., 2009; Nishimoto et al., 1999).
Phosphorylation increases AQP2 membrane accumulation by
inhibiting its clathrin-mediated endocytosis (Bouley et al., 2006;
Brown et al., 2008; Lu et al., 2007; Moeller et al., 2010; Sun et
al., 2002), but the role of phosphorylation in the exocytotic
process remains to be clarified. It is also well established that the
filamentous structure of actin is affected by vasopressin
stimulation (Hays et al., 1993). In rat kidney inner medullary
collecting duct cells and in toad bladder epithelial cells,
filamentous actin (F-actin) depolymerization after arginine
vasopressin (AVP) treatment was reported 20 years ago (Ding
et al., 1991; Simon et al., 1993).
Since the discovery of aquaporins, several studies have shown
that VP mediated AQP2 plasma membrane accumulation
involves F-actin depolymerization. Cytochalasin D, an F-actin
depolymerizing agent, induces AQP2 plasma membrane
accumulation in rabbit collecting duct CD8 cells (Tamma et al.,
2001). Inhibition of RhoA, which stimulates actin polymerization
in its active form, by Clostridium difficile toxin B, or inhibition of
Rho kinase, an important Rho downstream effector, by Y-27632
both result in AQP2 plasma membrane accumulation (Klussmann
et al., 2001; Tamma et al., 2001). The adenylyl cyclase activator
forskolin (FK), which also stimulates AQP2 membrane
accumulation, increases RhoA phosphorylation and binding to
RhoGDI, thus stabilizing the inactive form of RhoA in CD8 cells
(Tamma et al., 2003). From the same group, it was reported that
moesin, an ERM protein, that mediates cross-linking between F-
actin and trans-membrane proteins is involved in FK mediated F-
actin depolymerization in CD8 cells (Tamma et al., 2005). We
recently showed that simvastatin induces AQP2 plasma
membrane accumulation through RhoA inactivation (Li et al.,
2011). Taken together, these data indicate that F-actin
depolymerization is crucial molecular step for AQP2 plasma
membrane accumulation.
In addition, AQP2 interactions with the actin regulating
proteins, SPA-1, and tropomyosin 5b, have been identified.
SPA-1 is a GTPase activating protein (GAP) for Rap1. FK
mediated AQP2 apical accumulation required the Rap1GAP
activity of SPA-1 in MDCK cells (Noda et al., 2004).
Research Article 101
B
i
o
l
o
g
y
O
p
e
nImportantly, the finding in MDCK cells that phosphorylation of
AQP2 decreases its affinity for globular actin (G-actin) but
increases its binding to the actin stabilizing protein tropomyosin
5b (Noda et al., 2008), suggests a ‘‘catalytic’’ function for AQP2
in VP- mediating F-actin depolymerization.
Recently, we established an exocytosis assay system by
expressing soluble secreted (ss) YFP in LLC-PK1 cells. In cells
transfected with AQP2, ssYFP was localized in many (but not all)
AQP2 containing vesicles. When these vesicles fuse with the
plasma membrane, ssYFP is released into the culture medium.
The released ssYFP can be quantified by measuring its
fluorescence (Nunes et al., 2008). Interestingly, a vasopressin
and forskolin (VP/FK) mediated burst of ssYFP exocytosis was
observed only in LLC-PK1 cells stably transfected with AQP2,
but not in AQP2 untransfected LLC-PK1 cells (Nunes et al.,
2008). This finding supports the notion that AQP2 in some way
‘‘catalyzes’’ the effect of VP/FK on cells–In this case, the
stimulation of exocytosis.
Overall, these findings have changed the concept of VP-
mediated AQP2 plasma membrane accumulation from ‘‘AQP2
accumulates in plasma membranes as a consequence of F-actin
depolymerization’’ to ‘‘AQP2 accumulates in the plasma
membrane after catalyzing F-actin re-organization’’. However,
a definitive study investigating whether AQP2 is indeed required
for VP-mediated F-actin depolymerization has not so far been
performed.
In the present study, therefore, we aimed to fill this knowledge
gap by investigating whether or not the VP/FK mediated F-actin
depolymerization is affected by AQP2 expression levels both in
MDCK cells and in LLC-PK1 cells. These are both well
established renal epithelial cell lines that have been extensively
used for AQP2 intracellular translocation studies. However, they
accumulate AQP2 in different plasma membrane domains upon
VP stimulation – apical in the case of MDCK (Deen et al., 1997),
and basolateral in the case of LLC-PK1 (Brown, 2003), providing
an opportunity to assess any potential differences in their VP-
induced actin depolymerization response.
Results
Validation of the F-actin quantification assay
The F-actin quantification assay used here has been applied
previously to several mammalian cells types, for example, CD8
cells (Tamma et al., 2005). However the adequacy of the assay for
MDCK cells or LLC-PK1 cells was not reported. Therefore, we
determined the adequacy of the assay for our MDCK and LLC-PK1
cells using latrunculin B (1 mM for 30 minutes), which directly
bindstoG-actin andinhibitsactinpolymerization (Wakatsuki etal.,
2001). In F-actin quantification assays, a striking and significant
50% decrease in F-actin was found both in MDCK and LLC-PK1
cells after latrunculin B treatment (Fig. 1). F-actin staining by
rhodamine phalloidin confirmed that the filamentous structure of
actin was greatly disrupted by latrunculin B in both cell types
(supplementary material Fig. S1). This major effect of latrunculin
B on F-actin was identical in cells with or without AQP2
transfection. We conclude that the F-actin quantification assay is
suitable for use in the cell lines that we are studying here.
AQP2 expression level in different MDCK and LLC-PK1
cell lines
For the purpose of the present study to test whether the level
of AQP2 expression affects VP/FK mediated F-actin
depolymerization, we used 5 cell lines in our experiments;
WT-MDCK, MDCK cells stably expressing a low level of rat
AQP2 (low-AQP2 MDCK), a higher level of AQP2 (high-AQP2
MDCK), WT LLC-PK1, and LLC-PK1 cells stably transfected
with rat AQP2 (LLC-PK1-AQP2).
Western blotting was performed to examine AQP2 expression
levels in these cell lines (Fig. 2). In untransfected LLC-PK1 cells,
no signal was detected at 25kD, but this band was strongly
detected in LLC-PK1-AQP2 cells (Fig. 2, B). High-AQP2
MDCK showed about 2 times more AQP2 signal (2.1460.01,
n53, P,0.05) compared to low-AQP2 MDCK cells (Fig. 2, A
and supplementary material Fig. S2). In contrast to WT LLC-PK1
cells, WT-MDCK cells showed a faint signal at the same
molecular weight as AQP2 suggesting endogenous AQP2
expression (Fig. 2, A). This finding was examined in more
detail below.
WT MDCK cells express low levels of endogenous AQP2
To test further whether endogenous AQP2 expression was indeed
present in WT-MDCK cells, we picked up 3 colonies from WT-
Fig. 1. Validation of F-actin quantification assay in MDCK and in LLC-
PK1 cells. MDCK and LLC-PK1 cells were treated with 1 mM latrunculin B for
30 minutes, then subjected to the rhodamine phalloidin based F-actin
quantification assay. A 50% significant reduction in F-actin content was
quantified both in MDCK cells (to 0.5460.09, mean 6 s.d., n55, P,0.001)
and in LLC-PK1 cells (to 0.5160.13, mean 6 s.d., n53, P,0.05). These results
demonstrate that the F-actin quantification assay is suitable for MDCK cells
and LLC-PK1 cells.
Fig. 2. AQP2 expression levels in MDCK and LLC-PK1 cell lines.
Three MDCK and two LLC-PK1 cell lines were subjected to semi quantitative
western blotting analysis to determine AQP2 expression levels. In MDCK cells
(Fig. 2A–left panels), high AQP2 expression cells showed about 2 times higher
AQP2 expression than low AQP2 expression cells. A faint AQP2 signal was
also detected in WT MDCK cells. In LLC-PK1 cells (Fig. 2B–right panels), WT
(untransfected) cells showed no AQP2 signal, whereas, AQP2 transfected cells
showed a strong AQP2 signal. 5 mg protein was loaded in each lane. GAPDH is
shown as a loading control.
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AQP2-MDCK cells contaminated the WT-MDCK cell pool. We
divided cells from these 3 selected clones into 3 groups, cultured
in DMEM (FBS 10%) containing 500 mg/ml geneticin (group 1),
DMEM without geneticin (group 2), and cultured in DMEM with
500 mg/ml geneticin after transfection with an empty pcDNA 3.1
vector to confer geneticin resistance (group 3). All of the cells in
group 1 died within 10 days, whereas some of cells in group 3
survived and became confluent. This shows that the 3 WT-
MDCK clones were geneticin sensitive, that they were not
contaminated with geneticin resistant AQP2 transfected cells.
Next we determined whether AQP2 signals could be detected or
not in these 6 clones (3 geneticin sensitive, 3 resistant) by western
blotting. In all clones, a faint 25 kD was detected by the AQP2 C-
17 antibody (sc9882) (supplementary material Fig. S3, A). In
addition, an antibody specific for the pS261 phosphorylated form
of AQP2 was applied. A strong band was detected in high-AQP2
MDCK cells, but faint bands were also detected in the 6 clones
from untransfected MDCK cells (supplementary material
Fig. S3, A). The specificity of the pS261 AQP2 antibody was
confirmed in our AQP2 transfected cells, and the pS261 AQP2
signal was strikingly decreased by VP/FK stimulation as
previously shown (supplementary material Fig. S3, B) (Tamma
et al., 2011). Furthermore, the faint signals detected by
polyclonal AQP2 antibody in WT-MDCK cells were
significantly increased after overnight incubation with dDAVP
(10 nM) (supplementary material Fig. S3, C). These data suggest
that AQP2 is endogenously expressed in our untransfected WT-
MDCK cells, that the basal expression level is very low, and that
expression can be increased by activation AQP2 gene
transcription with VP.
VP/FK mediated F-actin depolymerization is correlated with
AQP2 expression levels in MDCK cells
To quantify changes in cellular F-actin content mediated by VP/
FK, MDCK cells were treated with or without VP/FK (AVP
20 nM and FK 50 mM) for the indicated times. To test whether
AQP2 expression level affects VP/FK mediated F-actin
depolymerization, we used clones in which AQP2 expression
levels were different, as shown in Fig. 2.
In all AQP2 transfected cells, the F-actin content was
significantly decreased at both 20 minutes and 60 minutes after
VP/FK addition compared to untransfected cells (Fig. 3, A),
However, a smaller but significant effect of VP/FK on F-actin
content was also observed in WT MDCK cells at 20 minutes, but
not at 60 minutes. As shown in Fig. 2 and supplementary
material Fig. S3, a low level of AQP2 was endogenously
expressed in the WT MDCK cells, which could explain this
small effect.
Next, we quantified the F-actin content of AQP2 transfected
MDCK cells compared to untransfected MDCK cells at the same
VP/FK time points, at 20 minutes and at 60 minutes (Fig. 3, B).
F-actin content was significantly lower in AQP2 transfected cells
than in untransfected cells at both time points. Furthermore, the
F-actin content of high-AQP2 MDCK cells was significantly
lower than low-AQP2 MDCK cells at 20 minutes and at
60 minutes VP/FK treatment (Fig. 3, B). We confirmed that the
b-actin expression level was not affected by VP/FK treatment in
high AQP2-MDCK cells, in which the VP/FK mediated F-actin
decrease was the most striking (supplementary material Fig. S4,
A). Taken together, these data demonstrate that VP/FK mediated
F-actin depolymerization is correlated with AQP2 expression
levels in these cells.
Fig. 3. VP/FK mediated F-actin depolymerization is
correlated with AQP2 expression levels in MDCK cells.
(A) MDCK cells were treated with or without VP/FK (20 nM
AVP and 50 mM FK) for indicated times, then F-actin was
quantified using the F-actin quantification assay shown in Fig. 1.
In higher AQP2 expressing cells (high-AQP2 MDCK, right
panel), F-actin was significantly decreased by VP/FK at both
20 minutes and 60 minutes. (n55,
*** P,0.001). In lower AQP2
expressing cells (low-AQP2 MDCK, center panel), F-actin was
also significantly decreased, but to a lesser extent, by VP/FK at
both 20 minutes and 60 minutes. (n55,
* P,0.05,
*** P,0.001).
In WT MDCK cells, F-actin was slightly but significantly
decreased by VP/FK at 20 minutes, but was not decreased at
60 minutes. (n55,
** P,0.01, NS5not significant). These figures
are representative of three independent experiments. (B) F-actin
content in each MDCK cell line at the same VP/FK time points
was compared using data from Fig. 3A. At both 20 minutes and
60 minutes, higher AQP2 expression is associated with a lower F-
actin content (n55, * P,0.05, ** P,0.01, *** P,0.001). These
figures are representative of three independent experiments.
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cells, but not in WT MDCK cells
We monitored F-actin staining and AQP2 translocation after VP/
FK treatment by confocal immunofluorescence microscopy in
MDCK cells. In high-AQP2 MDCK cells, AQP2 was located
intracellularly and sub-apically under non-stimulated conditions
(Fig. 4, A, panel a), After VP/FK treatment (AVP 20 nM and FK
50 mM for 60 minutes), AQP2 accumulated at the level of apical
plasma membrane (Fig. 4, A, compare panel b and c to panel a).
The intensity of apical F-actin signal was selectively and
obviously decreased by VP/FK treatment when examining the
z-plane sections (Fig. 4A, compare panel e and f to panel d); in
contrast, the intensity of the lateral F-actin signal was not
changed by VP/FK (Fig. 4, A, panel d and e). The VP/FK
mediated selective apical F-actin decrease was not observed in
WT MDCK cells (Fig. 4, A, see panel j and k, compare panel
k to panel e). The apical and basolateral fluorescence intensities
were compared using ImageJ (Fig. 4, B). In high-AQP2 MDCK
cells, a significant 60% decrease of apical F-actin signal was
detected, whereas, the basolateral F-actin signal was not
significantly decreased after 60 minutes VP/FK treatment
(Fig. 4, B). In WT-MDCK cells, no significant decrease of
the F-actin signal was detected either in apical or basolateral
cellular domains (Fig. 4, B). These results are in accordance
with the results of the F-actin quantification assay shown in
Fig. 3.
VP/FK induces a decrease in F-actin in AQP2 expressing LLC-
PK1 cells, but not in WT LLC-PK1 cells
Next, we performed F-actin quantification assays using WT
LLC-PK1 cells and LLC-PK1-AQP2 cells. Cells were treated
with or without VP/FK (LVP 20 nM, FK 10 mM) for the
indicated times, then subjected to F-actin quantification. In LLC-
PK1-AQP2 cells, the F-actin content was significantly decreased
after VP/FK treatment compared to untreated cells. In contrast, a
VP/FK mediated F-actin decrease was not detected in WT LLC-
PK1 cells. We confirmed that b-actin expression levels were not
affected by VP/FK treatment in LLC-PK1-AQP2 cells, in which a
significant F-actin decrease was found. (supplementary material
Fig. S4, B).
Fig. 4. Apical F-actin content is decreased by VP/FK in
AQP2-MDCK cells, but not in WT MDCK cells. (A) MDCK
cells were stained with AQP2 antibody (green) and rhodamine
phalloidin (red) with or without VP/FK treatment (AVP 20 nM
and FK 50 mM for 60 minutes). The larger panels represent
confocal sections through the middle or apical regions of the cells
as indicated. The smaller horizontal strips at the bottom of each
panel are Z-sections that clearly show apical and basolateral cell
membranes for direct comparison of their respective staining
intensities. In high AQP2-MDCK cells, intracellular and
subapical localization of AQP2 was detected under non-
stimulated conditions (panels a, g), with well defined cortical F-
actin staining both apically and basolaterally (panels d, g). Upon
stimulation by VP/FK, AQP2 was strongly accumulated in the
apical plasma membrane, and intracellular AQP2 signals could
not be detected (panels b, c and h, i). A selective decrease of the
apical F-actin was evident (panels e, f and h, i), but the basolateral
F-actin staining was not decreased by VP/FK (panels d, e). A VP/
FK-induced (same concentration and incubation time) selective
apical F-actin signal decrease was not detectable in WT-MDCK
cells (panels j, k). The images are representative of three
independent experiments. Scale bars, 10 mm. (B) F-actin
fluorescence in MDCK cells was analyzed using ImageJ. All
images were acquired under identical microscope parameters
within the linear range of intensity. No thresholding was applied
to the image prior to quantification. A region of interest (ROI)
was drawn over both apical and basolateral membranes for
quantification. Background intensities were evaluated from an
ROI drawn over the nucleus, and were subtracted from the
membrane ROI intensities. In high AQP2-MDCK cells, a
significant 60% decrease of apical F-actin fluorescence was
observed after VP/FK treatment (1.0060.05 to 0.4160.02). In
contrast, basolateral F-actin fluorescence was not significantly
decreased by VP/FK treatment (1.0060.07 to 1.0760.07) (right
graphs). The selective VP/FK mediated apical F-actin signal
decrease was not detected in WT (untransfected) MDCK cells
(apical: 1.0060.04 to 1.0760.04, basolateral: 1.0060.04 to
1.0760.05) (left graphs). Quantification shows the means of more
than 20 cells taken from three independent experiments (means 6
s.e.,
*** P,0.001, NS5not significant).
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localization are inversely related in LLC-PK1-AQP2 cells
In LLC-PK1-AQP2 cells, AQP2 was located intracellularly under
non-stimulated conditions, and accumulated in lateral plasma
membranes after VP/FK treatment (Fig. 6, compare b to a). F-
actin signals were markedly, but heterogeneously decreased after
VP/FK treatment (Fig. 6, compare e to d). Interestingly, F-actin
signals and AQP2 signals after VP/FK treatment showed an
inverse relationship like puzzle pieces (Fig. 6, see b, e and h,
more remarkable at the high magnification shown in c, f and i),
suggesting that VP/FK mediated F-actin depolymerization
occurred together with AQP2 plasma membrane accumulation.
The selective F-actin decrease mediated by VP/FK was not
observed in WT LLC-PK1 cells (Fig. 6, see j and k). These
results were in accordance with F-actin quantification assay
shown in Fig. 5 as well as MDCK experiments.
AQP2 knockdown blunts the VP/FK mediated F-actin decrease
in LLC-PK1-AQP2 cells
Contrary to MDCK cells, we tested only one AQP2 transfected
LLC-PK1 clone. Because of the possibility that F-actin
organization in this LLC-PK1-AQP2 clone could be especially
susceptible to VP/FK stimulation even if AQP2 was not
expressed, we performed siRNA-mediated AQP2 knockdown in
this cell line (Fig. 7). AQP2 expression was strikingly decreased
48 hours after AQP2 siRNA transfection (Fig. 7, A) and the VP/
FK mediated F-actin depolymerization rate was significantly
blunted by AQP2 knockdown (Fig. 7, B). Note that F-actin
depolymerization was not totally suppressed compared to
untransfected cells, reflecting the continued expression of small
amount of AQP2 even after siRNA-mediated knockdown. These
data further support the necessity of AQP2 expression for VP/FK
mediated F-actin depolymerization.
Intracellular cAMP measurement in MDCK and LLC-PK1
cell lines
Finally, we tested whether the VP/FK induced increase in
intracellular cAMP concentration was similar among MDCK cell
lines and LLC-PK1 cell lines (supplementary material Fig. S5).
In MDCK cells, VP/FK increased cAMP in all cell lines to a
similar degree (supplementary material Fig. S5, left graph). In
both WT LLC-PK1 and LLC-PK1-AQP2 cells, cAMP
concentrations were not significantly different after VP/FK
treatment (supplementary material Fig. S5, right graph). These
data show that all cell clones used in this study react similarly to
VP/FK treatment. The blunted VP/FK mediated F-actin
depolymerization found in untransfected MDCK cells and
the lack of VP/FK mediated F-actin depolymerization in
untransfected LLC-PK1 cells is not due to impaired sensitivity
to VP/FK.
Discussion
In the present study, we show that F-actin depolymerization
mediated by VP/FK stimulation is correlated with AQP2
expression levels, and that F-actin depolymerization is closely
associated with AQP2 plasma membrane accumulation in both
Fig. 5. VP/FK induces a decrease in F-actin in AQP2 expressing LLC-PK1
cells, but not in WT LLC-PK1 cells. LLC-PK1 cells were treated with or
without VP/FK (LVP 20 nM and FK 10 mM for indicated times), then subjected
to F-actin quantification assay. In AQP2 expressing LLC-PK1 cells (LLC-PK1-
AQP2), F-actin content was decreased by VP/FK at both 20 minutes and
60 minutes. In WT LLC-PK1 cells, F-actin content was not decreased by VP/
FK at either 20 minutes and 60 minutes (n55,
** P,0.01,
*** P,0.001,
NS5not significant). These figures are representative of three
independent experiments.
Fig. 6. AQP2 membrane accumulation and F-actin
membrane localization are inversely related in LLC-PK1-
AQP2 cells. LLC-PK1 cells were stained with AQP2 antibody
(green) and rhodamine phalloidin (red) with or without VP/FK
treatment (LVP 20 nM and FK 10 mM for 20 minutes). AQP2 was
located intracellularly (panels a, g) with well defined basolateral
cortical F-actin under non-stimulated conditions (panels d, g).
After VP/FK treatment, AQP2 accumulated in lateral plasma
membranes (panels b, c) where F-actin depolymerization was
clearly detectable in a heterogeneous pattern (panels e, f). There
was a clear inverse relationship between the intensity of F-actin
staining and AQP2 membrane accumulation (panels b, e, and h).
This inverse relationship between AQP2 and F-actin after VP/FK
treatment is more clearly appreciated at high magnification
(panels c, f, and i). The VP/FK-mediated (same concentration and
incubation time) selective decrease of F-actin signal was not
observed in untransfected LLC-PK1 cells (panels j, k). The images
are representative of three independent experiments. Scale bars,
10 mm.
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epithelial cell lines.
Compared to latrunculin B mediated ‘global’ F-actin
depolymerization, the extent of VP/FK mediated F-actin
depolymerization was relatively lower both in MDCK and
LLC-PK1 cells. However, as shown by immunofluorescence
staining, VP/FK mediated F-actin depolymerization occurred
‘locally’ and was closely related to AQP2 plasma membrane
accumulation. We believe, therefore, the smaller (about 10%)
decrease in total cellular F-actin measured after VP/FK treatment
probably is an underestimate of the local actin changes that occur
in the vicinity of AQP2 target membranes. Interestingly, similar
changes were seen in both cell types, independently of the
polarity of membrane insertion (apical in MDCK versus
basolateral in LLC-PK1) of AQP2. This is consistent with the
idea that AQP2 itself is influencing local actin polymerization at
or close to its site of membrane accumulation, since no
depolymerization was seen in the absence of AQP2.
In MDCK cells, F-actin depolymerization rates were clearly
related to AQP2 expression levels at the same VP/FK time point.
However, a smaller F-actin depolymerization effect was also
observed in untransfected MDCK cells. We found subsequently
that very low AQP2 signals are detected even in untransfected
MDCK cells. The signal was also revealed by another AQP2
antibody (pS261-AQP2 antibody), and was significantly
increased by overnight exposure to dDAVP (10 nM), consistent
with previous data showing the presence of cAMP responsive
element in the AQP2 gene promoter (Hozawa et al., 1996;
Matsumura et al., 1997; Yasui et al., 1997). So far, there is little
or no evidence that VP affects post-translational regulation of
AQP2 abundance. Because the effect of VP/FK in these WT
MDCK cells was reduced compared to AQP2 transfected cells,
these results further support the concept that AQP2 is required for
VP/FK mediated F-actin depolymerization.
Our present results also provide a potential explanation of our
previous data using an ssYFP exocytosis assay in LLC-PK1 cells,
as described above (Nunes et al., 2008). We found that VP/FK-
induced a rapid burst of ssYFP exocytosis in transfected LLC-
PK1-AQP2 cells but not in untransfected LLC-PK1 cells (Nunes
et al., 2008). Since actin remodeling is necessary for AQP2
trafficking, we conclude that VP/FK mediated F-actin
depolymerization is dependent on AQP2 expression, and is
necessary for VP-induced exocytosis in LLC-PK1 cells.
Previous pioneering findings performed prior to the discovery
of AQP2 also showed that AVP treatment depolymerizes F-actin
in rat inner medullary collecting duct cells (Simon et al., 1993)
and in toad bladder epithelial cells (Ding et al., 1991). Toad
bladder epithelial cells also express an aquaporin, known as
AQP-TB which is 44% identical to rat-AQP2 and may also have
a similar effect on the actin cytoskeleton (Siner et al., 1996).
Furthermore, Holmgren et al reported that the AVP-induced actin
depolymerization was restricted to the apical pole of the cell,
where water channels (now identified as AQP2) are inserted
(Holmgren et al., 1992). This effect was believed to be due to the
VP-induced removal of an apical actin ‘‘barrier’’ that impeded the
access of water-channel transporting vesicles to the plasma
membrane (Ding et al., 1991).
Our current results also support the notion that AQP2 catalyses
F-actin depolymerization by FK via interaction with actin
regulating proteins, including SPA-1 and tropomyosin 5b
(Noda et al., 2004; Noda et al., 2008). The effect of RhoA or
ERM proteins on F-actin depolymerization might also require the
presence of AQP2, but this has not yet been examined. In the
view of vast array of actin regulatory proteins (Saarikangas et al.,
2010), including Rho GEFs, GAPs, GDIs (Ridley, 2006), it is
likely that the interaction AQP2 with tropomyosin-5b and SPA-1
are only the tip of a vast iceberg of actin signaling complexes that
involve AQP2. Indeed, interactions between AQP2 containing
vesicles and actin-related proteins, including ARP2/3 and
gelsolin, which interacts with PI(4,5)P2, were identified in
isolated rat inner medullary collecting ducts (Barile et al., 2005).
The molecular mechanisms by which AQP2 interacts with
many of these actin regulating proteins have yet to be
investigated, but deeper understanding of the cell physiology of
AQP2/actin associations might contribute to the development of
new strategies for treatment of water balance disorders including
nephrogenic diabetes insipidus (NDI) and congestive heart failure
(CHF). Indeed, we recently showed that statins induce the plasma
membrane accumulation of AQP2 and increase urinary
concentration in Brattleboro rats by inhibiting RhoA. This
results in actin depolymerization, and inhibits endocytosis, thus
allowing increased AQP2 membrane accumulation to occur (Li et
al., 2011). Our present results show a clear inverse relationship
between the presence of F-actin close to the plasma membrane,
and AQP2 membrane accumulation. This could reflect local
‘‘hotspots’’ of either accumulation of AQP2 due to impaired
Fig. 7. AQP2 knock down blunts the VP/FK mediated F-actin
decrease in LLC-PK1-AQP2 cells. (A) A highly significant 80%
decrease in AQP2 protein expression was achieved by transfection
of 80 nM AQP2 siRNA into LLC-PK1-AQP2 cells. 5 mg protein
was loaded in each lane. After AQP2 detection, the same PVDF
membrane was stripped, reprobed with GAPDH antibody as a
loading control. Band intensity was analyzed using ImageJ (Mean
6 s.d., n53,
*** P, 0.001). (B) In AQP2 knockdown cells, F-
actin content was still decreased by VP/FK treatment (black bars),
but the decrease was significantly blunted compared to cells
without siRNA induced AQP2 knockdown (compare black bars to
gray bars, mean 6 s.d., n55, ** P, 0.01). The figure is
representative of three independent experiments.
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or the reverse situation (inhibition of exocytosis and stimulation
of endocytosis) in the membrane regions where F-actin is
abundant. Since our prior data indicate that AQP2 is required for
the VP-induced exocytosis of ssYFP in LLC-PK1 cells, it is likely
that, as discussed earlier, AQP2/actin association and signaling
processes have multiple cellular effects on the AQP2 recycling
pathway.
Materials and Methods
Reagents
Lysine vasopressin (LVP), arginine vasopressin (AVP), deamino-Cys1, D-Arg8
vasopressin (dDAVP), forskolin (FK), latrunculin B (LtB), rhodamine phalloidin
(Phalloidin Tetramethylrhodamine B isothiocyanate) were purchased from Sigma
Aldrich (MO). Goat AQP2 antibody (sc9882, Santa Cruz, CA), mouse anti
GAPDH antibody (AM4300, Ambion, CA), mouse anti b-actin antibody (A5441,
Sigma Aldrich, MO), donkey anti goat antibody FITC conjugated (Jackson
ImmunoResearch, PA), donkey anti goat antibody HRP conjugated (Santa Cruz,
CA), donkey anti rabbit antibody HRP conjugated (Santa Cruz, CA), donkey anti
mouse antibody HRP conjugated (Santa Cruz, CA) were used following the
manufacturer’s protocol.
Cell culture
MDCK and LLC-PK1 cells stably expressing rat AQP2 were generated as
described previously (Lu et al., 2004; Yui et al., 2009). WT MDCK cells and WT
LLC-PK1 cells were parental cells of these AQP2 transfected clones, respectively.
The cells were cultured in DMEM containing 10% FBS in a 5% CO2 incubator at
37˚C under neomycin selection for transfected cells (500 mg/ml), passaged using
TrypLE (GIBCO-BRL). 24 hours before experiments, culturing DMEM was
replaced with fresh FBS 10% DMEM without antibiotics. The adenylyl cyclase
activator forskolin (FK) was used in combination with the V2R agonist vasopressin
(VP) to ensure that a maximum response was elicited in the cells.
Western blotting
Cells were grown on 6 well plates for at least 3 days and lysed in RIPA buffer
(500 ml for MDCK, 250 ml for LLC-PK1 cells) supplemented with a Complete
Mini (1 tablet/40 ml RIPA buffer). Lysate was rotated for 30 min at 4˚C and
centrifuged for 10 min at 10,000 rpm. Protein concentration in each sample was
determined using a BCA kit (PIERCE). Samples were diluted in RIPA buffer and
35 ml NuPage SDS sample buffer to a protein concentration of 50 mg in 100 ml
loading solution. 10 ml reduced samples (5 mg protein) per lane were run on a
NuPage 1.0-mm 15 well 4–12% Bis-Tris gel for ,90 min at 80 V, transferred onto
PVDF membrane (LC2002, Invitrogen, CA) for 90 minutes at 100 V. The
transferred PVDF membranes were incubated in 5% skimmed milk in 0.05%
PBST at 4˚C overnight, then incubated with primary antibody, diluted 1:10,000 in
0.05% PBST for 1h (AQP2 polyclonal antibody, GAPDH antibody, and b-actin
antibody), or overnight (pS261 AQP2 antibody) at 4˚C. Then PVDF membranes
were washed 4 times for 15 min in 0.05% PBST, incubated with HRP conjugated
secondary antibody diluted 1:10,000 for 30 min, washed in 0.05% PBST 4 times
for 15 min. Signals were visualized using Western Lightning ECL and Biomax
XAR film. For loading controls, antibodies on PVDF membranes were stripped in
stripping buffer (0.2M glycine, 0.05% Tween 20, pH was adjusted to 2.5 by adding
HCl) for 1 h, were blocked in 5% skimmed milk/PBST again for 15 minutes, then
reprobed with mouse GAPDH antibody (diluted 1:10,000). Band intensities were
analyzed by ImageJ.
Immunocytochemistry
8610
4 cells were plated on coverslips (for MDCK cells) in 24 wells or Transwell
filters (Costar 3460, for LLC-PK1 cells) in 12 wells. After 2 days for MDCK cells
and 3 days for LLC-PK1 cells, polarized monolayers were formed. MDCK cells
were treated with 50 mM indomethacin overnight (Deen et al., 1997) before
experiments to reduce endogenous cAMP levels. Serum containing DMEM was
replaced with pre-warmed, serum and antibiotic-free DMEM for 2 hours, then VP/
FK (AVP 20 nM and FK 50 mM for MDCK cells, LVP 20 nM and FK 10 mM for
LLC-PK1 cells, final concentration) or latrunculin B (1 mM, final concentration)
were added to the medium. After incubation for various times, cells were fixed
with 4% paraformaldehyde at 37˚C for 10 minutes. Cells were washed in PBS 3
times, permeabilized with 0.1% Triton-X/PBS for 10 minutes, washed in PBS,
blocked in 1% BSA/PBS for 30 min at room temperature. AQP2 antibody was
diluted 1:1,000 in 1%BSA/PBS, incubated overnight at 4˚C. Cells were washed in
PBS (10 min, 3 times), incubated with 1:1,000 diluted donkey anti goat IgG, FITC
conjugated antibody for 3 hours at room temperature, then washed in PBS
(10 min, 3 times). Finally, cells were incubated with 20 nM rhodamine-phalloidin
diluted in cold PBS for 20 min on ice. Cells were washed in PBS (10 min, 3
times), then mounted on glass slides with Vectashield mounting medium (Vector
Labs. Burlingame. CA).
F-actin quantification assay
8610
4 cells were plated on 24 well plates, and incubated in normal DMEM for 2
days (LLC-PK1) or 3 days (MDCK). MDCK cells were treated with 50 mM
indomethacin overnight prior to use (Deen et al., 1997). DMEM was replaced with
HBSS and cells were incubated for 2 hours. After treatment with VP/FK or
Latrunculin B as above for various times, HBSS buffer was removed and cells
were incubated in binding buffer containing phalloidin (20 mM KH2PO4,1 0m M
PIPES, 5 mM EGTA, 2 mM MgCl2, 4% PFA, 0.1% TritonX-100, 250 nM
rhodamine phalloidin) for 15 min at room temperature. Negative controls to
estimate background autofluorescence were prepared using binding buffer
lacking rhodamine-phalloidin. Cells treated with binding buffer were washed 4
times in PBS, incubated in 300 ml (in each well) methanol overnight at 220˚Ct o
extract bound rhodamine-phalloidin. The extracted rhodamine-phalloidin
fluorescence was read using a Beckman DTX-880 multi-plate reader (excitation
535 nm, emission 595 nm). F-actin content values were expressed as relative
fluorescence after subtraction of the negative-control values. Data was adjusted for
protein concentration. Each fluorescence value was expressed as relative
fluorescence unit (RFU)/protein (mg) and data were analyzed using a two-tailed
Student’s t-test.
RNA interference
Duplex siRNAs for AQP2 knockdown (59-CUGCCAUCCUCCAUGAGAU-39,5 9-
AUCUCAUGGAGGAUGGCAG-39) were purchased from Sigma Aldrich, and
diluted in distilled water to 20 mM. 10
5 LLC-PK1 cells were plated on 6 well
plates and incubated overnight. Next day, DMEM was replaced with serum free
medium. 80 nM AQP2 siRNA (per well in 1 ml serum free DMEM) was
transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). 6 h after adding
siRNA, serum free DMEM was replaced with 10% FBS DMEM. 48 hours after
transfection, cells were lysed in 200 ml RIPA buffer and subjected to western
blotting analysis, or cells were subjected to F-actin quantification assay as
described above. Negative controls were prepared using Lipofectamine 2000
without AQP2 siRNA.
Intracellular cAMP measurement
Cells were plated on 96 well plates, were treated with or without VP/FK as above,
then analyzed using an ELISA based cAMP Biotrak enzyme immunoassay
(Amersham Biosciences) according to the manufacturer’s protocol. MDCK cells
were treated with 50 mM indomethacin overnight before exposure to VP/FK.
Absorbance values at 450 nm were measured using the DTX880 plate reader. The
results were adjusted by cell number, and analyzed by a two-tailed Student’s t-test.
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